The Trump administration's attempt to overhaul how safety net hospitals pay for outpatient drugs has run into a major legal ...

Following Eli Lilly and Johnson & Johnson, Sanofi is aiming to change how it participates in the 340B program, a federal drug pricing program created in 1992, The Wall Street Journal reported Nov. 22.

The 340B Drug Discount Program was designed to help safety-net providers make drugs available to low-income patients and earn revenue. Drug manufacturers have put restrictions on which pharmacies ...

The U.S. Department of Health and Human Services is appealing Monday's ruling that affects how much hospitals pay for drugs ...

In May 2025, Gov. Jared Polis signed Senate Bill 71 into law, dramatically expanding Colorado’s participation in the 340B ...

The 340B program is criticized for generating revenue rather than solely aiding underinsured patients, impacting community providers and Medicare patients. Pharmaceutical companies face challenges ...

WASHINGTON: The U.S. Department of Health and Human Services building is shown in Washington, DC. (Photo by Mark Wilson/Getty Images) In 1992, Congress created the 340B Drug Pricing Program to provide ...

On July 31, the US Department of Health and Human Services’ (HHS) Health Resources and Services Administration (HRSA) announced the availability of a new pilot program altering how pharmaceutical ...

The 340B drug pricing program is complicated. A clinic leader and a hospital said that’s making it easy for there to be misunderstandings about if the savings are being passed onto the patient.

As the Trump administration prepares to force its Most Favored Nation price controls on drug makers, a major U.S. lobbying group is pushing for a change to drug discounts law that would necessitate a ...

The use of targeted therapy was similar between patients living in areas with the highest 340B penetration and patients living in areas with the lowest 340B penetration. Participation in the 340B Drug ...